Compounds > mesalamine

mesalamine and azomycin

mesalamine has been researched along with azomycin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dijkstra, G; Nieuwenhuijs, VB; Ploeg, RJ; van Loo, ES1
Watanabe, T; Yamamoto, T1
Burr, NE; Ford, AC; Hall, B; Hamlin, PJ; O'Connor, A; Selinger, CP1

Reviews

3 review(s) available for mesalamine and azomycin

ArticleYear
Prevention of postoperative recurrence of Crohn's disease.
    Journal of Crohn's & colitis, 2012, Volume: 6, Issue:6

    Topics: Anastomosis, Surgical; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Interleukin-10; Intestine, Small; Laparoscopy; Mercaptopurine; Mesalamine; Nitroimidazoles; Probiotics; Secondary Prevention; Treatment Outcome

2012
Strategies for the prevention of postoperative recurrence of Crohn's disease.
    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2013, Volume: 15, Issue:12

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colectomy; Colon; Colonoscopy; Crohn Disease; Humans; Ileum; Immunosuppressive Agents; Infliximab; Intestinal Perforation; Mercaptopurine; Mesalamine; Nitroimidazoles; Odds Ratio; Proportional Hazards Models; Risk Factors; Secondary Prevention; Smoking; Treatment Outcome

2013
Systematic Review and Network Meta-Analysis of Medical Therapies to Prevent Recurrence of Post-Operative Crohn's Disease.
    Journal of Crohn's & colitis, 2019, May-27, Volume: 13, Issue:6

    Topics: Anti-Inflammatory Agents; Crohn Disease; Humans; Mesalamine; Nitroimidazoles; Secondary Prevention; Tumor Necrosis Factor-alpha

2019